Oana Cristina Maximov

Dr. Oana Cristina Maximov


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2020 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Natalia BeshchasnaNatalia Beshchasna
Natalia Beshchasna
Muhammad SaqibMuhammad Saqib
Muhammad Saqib
HKHonorata Kraskiewicz
Honorata Kraskiewicz
ŁWŁukasz Wasyluk
Łukasz Wasyluk
OKOleg Kuzmin
Oleg Kuzmin
EAEcaterina Andronescu
Ecaterina Andronescu
Cardiovascular diseases are the most distributed cause of death worldwide. Stenting of arteries as a percutaneous transluminal angioplasty procedure became a promising minimally invasive therapy based on re-opening narrowed arteries by stent insertion. In order to improve and optimize this method, many research groups are focusing on designing new or improving existent stents. Since the beginning of the stent development in 1986, starting with bare-metal stents (BMS), these devices have been continuously enhanced by applying new materials, developing stent coatings based on inorganic and organic compounds including drugs, nanoparticles or biological components such as genes and cells, as well as adapting stent designs with different fabrication technologies. Drug eluting stents (DES) have been developed to overcome the main shortcomings of BMS or coated stents. Coatings are mainly applied to control biocompatibility, degradation rate, protein adsorption, and allow adequate endothelialization in order to ensure better clinical outcome of BMS, reducing restenosis and thrombosis. As coating materials (i) organic polymers: polyurethanes, poly(ε-caprolactone), styrene-b-isobutylene-b-styrene, polyhydroxybutyrates, poly(lactide-co-glycolide), and phosphoryl choline; (ii) biological components: vascular endothelial growth factor (VEGF) and anti-CD34 antibody and (iii) inorganic coatings: noble metals, wide class of oxides, nitrides, silicide and carbide, hydroxyapatite, diamond-like carbon, and others are used. DES were developed to reduce the tissue hyperplasia and in-stent restenosis utilizing antiproliferative substances like paclitaxel, limus (siro-, zotaro-, evero-, bio-, amphi-, tacro-limus), ABT-578, tyrphostin AGL-2043, genes, etc. The innovative solutions aim at overcoming the main limitations of the stent technology, such as in-stent restenosis and stent thrombosis, while maintaining the prime requirements on biocompatibility, biodegradability, and mechanical behavior. This paper provides an overview of the existing stent types, their functionality, materials, and manufacturing conditions demonstrating the still huge potential for the development of promising stent solutions.

13 November 2021 in Coatings
Verified
Journal Article
Open access
PDF file
MMMaxim V. Maximov
Maxim V. Maximov
OMOana Cristina Maximov
Oana Cristina Maximov
LCLuminita Craciun
Luminita Craciun
Denisa FicaiDenisa Ficai
Denisa Ficai
Anton FICAIAnton FICAI
Anton FICAI
EAEcaterina Andronescu
Ecaterina Andronescu
Diseases or complications that are caused by bone tissue damage affect millions of patients every year. Orthopedic and dental implants have become important treatment options for replacing and repairing missing or damaged parts of bones and teeth. In order to use a material in the manufacture of implants, the material must meet several requirements, such as mechanical stability, elasticity, biocompatibility, hydrophilicity, corrosion resistance, and non-toxicity. In the 1970s, a biocompatible glassy material called bioactive glass was discovered. At a later time, several glass materials with similar properties were developed. This material has a big potential to be used in formulating medical devices, but its fragility is an important disadvantage. The use of bioactive glasses in the form of coatings on metal substrates allows the combination of the mechanical hardness of the metal and the biocompatibility of the bioactive glass. In this review, an extensive study of the literature was conducted regarding the preparation methods of bioactive glass and the different techniques of coating on various substrates, such as stainless steel, titanium, and their alloys. Furthermore, the main doping agents that can be used to impart special properties to the bioactive glass coatings are described.

28 March 2025 in Coatings
Verified
Journal Article
Open access
PDF file
MMMaxim V. Maximov
Maxim V. Maximov
OMOana Cristina Maximov
Oana Cristina Maximov
Ludmila MotelicaLudmila Motelica
Ludmila Motelica
Denisa FicaiDenisa Ficai
Denisa Ficai
Ovidiu-Cristian OpreaOvidiu-Cristian Oprea
Ovidiu-Cristian Oprea
IGIrina Gheorghe
Irina Gheorghe
This paper describes the synthesis and evaluation of samarium-doped 45S5 bioactive glass in various ratios. The bioactive glass samples were prepared using the sol–gel method and subjected to a heat treatment at 700 °C in normal atmosphere. The obtained samples were analyzed by thermogravimetric analysis (TGA) before and after the heat treatment to assess their thermal stability and compositional changes. The bioactivity of the samples was tested in vitro by immersion in simulated body fluid (SBF) at 36.5 ± 0.5 °C (normal human body temperature) and pH 7.4 (the pH of the human blood plasma), for several time periods. During the test, the pH and conductivity of the SBF solutions were monitored to track ion migration. After the in vitro test, the mass loss was evaluated and the formation of hydroxycarbonate apatite (HCA) was analyzed by FTIR spectroscopy. The microstructure of the bioactive glasses was examined using scanning electron microscopy (SEM) and the density of bioactive glass was also determined using Archimedes’ principle. This study also investigated the antimicrobial and anti-biofilm properties of both undoped and samarium-doped 45S5 bioactive glass through qualitative and quantitative assays against a range of microorganisms, including Gram-negative, Gram-positive, and yeast reference strains. The results were compared with literature data on melt-derived bioactive glass to evaluate the effects of Sm doping and the sol–gel synthesis method on bioactive glass performance.

30 July 2019 in Medicina
Verified
Journal Article
Open access
PDF file
OMOana Cristina Maximov
Oana Cristina Maximov
MMMaxim V. Maximov
Maxim V. Maximov
RTRoxana Trușcă
Roxana Trușcă
Anton FICAIAnton FICAI
Anton FICAI
Denisa FicaiDenisa Ficai
Denisa Ficai
EAEcaterina Andronescu
Ecaterina Andronescu
Background and objectives: Medical devices such as catheters are used on a large scale to treat heart and cardiovascular diseases. Unfortunately, they present some important drawbacks (structure failure, calcifications, infections, thrombosis, etc.), with the main side effects occurring due to adhesion and proliferation of bacteria and living cells on the surface of the implanted devices. The aim of this work is to modify the surface of polyvinyl chloride (PVC), an affordable biocompatible material, in order to reduce these aforementioned side effects. Materials and Methods: The surface of PVC was modified by depositing a thin layer also of PVC that incorporates an active substance, dicoumarol (a well-known anticoagulant), by spin coating process. The modified surfaces were analyzed by Fourier-transform infrared (FT-IR) microscopy, Fourier-transform infrared (FT-IR) spectroscopy, Ultraviolet-visible spectroscopy (UV-VIS), and Scanning electron microscopy (SEM) in order to determine the surface morphology and behavior. The samples were tested for Gram-positive (S. aureus ATCC 25923) and Gram-negative (P. aeruginosa ATCC 27853) standard strains from American Type Culture Collection (ATCC). Results: The material obtained had a smooth surface with a uniform distribution of dicoumarol, which is released depending on the deposition parameters. The concentration of dicoumarol at the surface of the material and also the release rate is important for the applications for which the surface modification was designed. PVC modified using the proposed method showed a good ability to prevent salt deposition and decreased the protein adhesion, and the resistance to bacterial adherence was improved compared with standard PVC.

26 September 2025 in Coatings
Verified
Journal Article
Open access
PDF file
MMMaxim V. Maximov
Maxim V. Maximov
LSLea Sleiman
Lea Sleiman
OMOana Cristina Maximov
Oana Cristina Maximov
RTRoxana Trușcă
Roxana Trușcă
Ludmila MotelicaLudmila Motelica
Ludmila Motelica
Sorina DinescuSorina Dinescu
Sorina Dinescu
Bioactive coatings are of great interest for orthopedic applications, as they combine mechanical stability with biological functionality. In this study, stainless steel discs were coated with 45S5 bioactive glass doped with 1.0 wt% samarium by spin coating, followed by surface functionalization with benfotiamine through spraying. This strategy integrates three components: a metallic substrate as a stable and inexpensive support, a bioactive glass layer with well-known osteogenic potential, and a superficial organic layer of benfotiamine, a lipid-soluble analog of vitamin B1 with higher bioavailability. Samarium doping was selected based on previously reported antimicrobial potential against clinically relevant staphylococci, while the rationale for benfotiamine functionalization derives from literature describing vitamin B1 derivatives with anti-resorptive and osteogenic activity. The coatings were characterized by scanning electron microscopy (SEM) and Fourier-transform infrared (FTIR) microscopy. Bioactivity was assessed by immersion in simulated body fluid (SBF), where phosphate bands indicated the formation of calcium phosphate phases (CaPs). Wettability tests showed a reduced contact angle after benfotiamine functionalization. Cytocompatibility was evaluated by LDH and MTT assays with MC3T3-E1 cells, suggesting overall biocompatibility and enhanced cell viability after 7 days for the benfotiamine-functionalized coatings. The present findings support a simple and cost-effective route to multifunctional coatings with potential relevance for future orthopedic applications.